ExPEC9V

九价肠外致病性大肠埃希菌疫苗

Report date: 2025/02/20 16:31:44

Base Information

Drug NameExPEC9V
Drug Alias Name9-valent Extraintestinal pathogenic Escherichia coli vaccine(Sanofi)JNJ-78901563SP0282SP-0282
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEscherichia coli Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[23] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJanssen Research & Development LlcJohnson & Johnson (China) Investment Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson (China) Investment LtdSanofiJanssen Research & Development Llc
Inactive CompaniesN/A
Active IndicationsEscherichia coli Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A